d-apv has been researched along with Hepatocellular Carcinoma in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Auriola, S; Bunch, L; Gynther, M; Han, L; Hansen, JC; Hansen, KB; Ishchenko, Y; Kayser, S; Larsen, Y; Malm, T; Nielsen, B; Petsalo, A; Pickering, DS; Proietti Silvestri, I | 1 |
1 other study(ies) available for d-apv and Hepatocellular Carcinoma
Article | Year |
---|---|
Augmentation of Anticancer Drug Efficacy in Murine Hepatocellular Carcinoma Cells by a Peripherally Acting Competitive N-Methyl-d-aspartate (NMDA) Receptor Antagonist.
Topics: Animals; Antineoplastic Agents; Carcinoma, Hepatocellular; Cell Line, Tumor; Drug Discovery; Drug Resistance, Multiple; Humans; Liver Neoplasms; Mice; Niacinamide; Phenylurea Compounds; Receptors, N-Methyl-D-Aspartate; Sorafenib | 2017 |